Antiparasitic Drugs Market
Antiparasitic Drugs Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Antiparasitic Drugs Market Size and Growth
The Antiparasitic Drugs market is experiencing significant growth, driven by rising incidences of parasitic infections and increasing awareness of preventive healthcare. The market size is projected to reach approximately $18 billion by 2025, supported by advancements in drug formulations and expanding healthcare access worldwide. Favorable government initiatives further enhance market potential.
Companies Covered
(Covid 19 Impact Covered)
◍ Ipca Laboratories Ltd
◍ Zydus Cadila
◍ Merck
◍ Pfizer
◍ GlaxoSmithKline Plc.
◍ Cipla Ltd
◍ Ranbaxy Laboratories
◍ Novartis AG
◍ Alvizia Health Care
◍ Bayer AG
◍ Roche Inc
◍ Arbor Pharmaceuticals Inc.
◍ Sanofi
◍ AstraZeneca
◍ Alkem Laboratories Limited
The antiparasitic drugs market features key players like Merck, Pfizer, and GlaxoSmithKline, focusing on innovation and strategic partnerships to enhance treatment options. Companies like Cipla and Alvizia Health Care contribute through affordable generics. Actual sales revenue figures include Merck: $48 billion, Pfizer: $80 billion, and Novartis: $51 billion.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Others
By Product
◍ by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
